Sign in
4

Changes in Ownership

Vaxcyte, Inc. Filed Acc 0001649094-24-000028

SVP, GEN COUNSEL & CORP SEC sold 1,667 shares at an average $76.37 ($127,304)

  • SVP, GEN COUNSEL & CORP SEC acquired 1,667 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC 2024-07-01 Option exercise 10b5-1 +1,667 $21.41 $35,690 32,493 D
Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC 2024-07-01 Sale 10b5-1 −913 $75.93 $69,322 31,580 D
Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC 2024-07-01 Sale 10b5-1 −754 $76.90 $57,982 30,826 D
Derivatives
Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC 2024-07-01 Option exercise · Stock Option (right to buy) 10b5-1 −1,667 183,331 D
Open-market sales · 1,667 sh · avg $76.37 · $127,304
Loading xslF345X05/wk-form4_1719951462.xml…